1. Table of Contents
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Zika Virus Infections Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Zika Virus Infections Clinical Trials by Region
2.2.2 Average Enrollment of Zika Virus Infections Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Zika Virus Infections Treatment, 2019

3. Region wise Zika Virus Infections Clinical Trials
3.1 Asia Pacific Zika Virus Infections Clinical Trials by Country
3.2 Europe Zika Virus Infections Clinical Trials by Country
3.3 North America Zika Virus Infections Clinical Trials by Country
3.4 Middle East and Africa Zika Virus Infections Clinical Trials by Country
3.5 South and Central America Zika Virus Infections Clinical Trials by Country

4. Zika Virus Infections Clinical Trial Trends
4.1 Start Year wise Zika Virus Infections Clinical Trials
4.2 Phase wise Zika Virus Infections Clinical Trials
4.3 Trial Status wise Zika Virus Infections Clinical Trials
4.4 Trial Type wise Zika Virus Infections Clinical Trials

5. Zika Virus Infections Average Enrollment Trends
5.1 Average Enrollment in Zika Virus Infections Trials by Year
5.2 Average Enrollment in Zika Virus Infections Trials by Phase
5.3 Average Enrollment in Zika Virus Infections Trials by Status
5.4 Average Enrollment in Zika Virus Infections Trials by Type of Trial

6. Companies Participating in Zika Virus Infections Clinical Trials
6.1 Zika Virus Infections Trials by Sponsor Type
6.2 Zika Virus Infections Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Zika Virus Infections Trials- Phase 1
7.2 Zika Virus Infections Trials- Phase 2
7.3 Zika Virus Infections Trials- Phase 3
7.4 Zika Virus Infections Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Zika Virus Infections Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Zika Virus Infections Clinical Trials and Enrolment
Figure 5: Europe – Country wise Zika Virus Infections Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Zika Virus Infections Clinical Trials and Enrolment
Figure 7: North America – Country wise Zika Virus Infections Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Zika Virus Infections Clinical Trials and Enrolment
Figure 9: Zika Virus Infections Clinical Trials by Phase
Figure 10: Zika Virus Infections Clinical Trials by Trial Status
Figure 11: Zika Virus Infections Clinical Trials by Type
Figure 12: Zika Virus Infections Clinical Trials by Sponsor Type
Figure 13: Zika Virus Infections Clinical Trials by Leading Sponsors
Figure 14: Zika Virus Infections Average Enrollment by Phase
Figure 15: Zika Virus Infections Average Enrollment by Trial Status
Figure 16: Zika Virus Infections Average Enrollment by Type
Figure 17: Zika Virus Infections- Average Enrolment by Type of Sponsors
Figure 18: Zika Virus Infections- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List of Tables
Table 1: Zika Virus Infections Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Zika Virus Infections Clinical Trials and Enrolment
Table 5: Europe – Country wise Zika Virus Infections Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Zika Virus Infections Clinical Trials and Enrolment
Table 7: North America – Country wise Zika Virus Infections Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Zika Virus Infections Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Zika Virus Infections Average Enrollment by Phase
Table 15: Zika Virus Infections Average Enrollment by Trial Status
Table 16: Zika Virus Infections Average Enrollment by Type
Table 17: Zika Virus Infections- Average Enrolment by Type of Sponsors
Table 18: Zika Virus Infections- Enrolment by Leading Sponsors

Companies mentioned
Ala Wai Pharma Inc, Alternate Health Corp, Bharat Biotech Ltd, Codagenix Inc, Emergent BioSolutions Inc, GeneOne Life Science Inc, Inovio Pharmaceuticals Inc, QPS Holdings LLC, Sanofi, Valneva SE